Dehydroepiandrosterone sulfate treatment of mice modulates infection with Schistosoma mansoni

Clin Diagn Lab Immunol. 1998 Mar;5(2):251-3. doi: 10.1128/CDLI.5.2.251-253.1998.

Abstract

Female mice treated with dehydroepiandrosterone sulfate early during infection were partially protected (P < 0.05-0.005) from Schistosoma mansoni infection. Hormone treatment did not modify parasite-specific cellular or humoral responses. Serum dehydroepiandrosterone sulfate levels and testosterone infection were negatively correlated, r = -0.621 and r = -0.653, respectively, with schistosome worm burden. The partial resistance to schistosome infection in dehydroepiandrosterone sulfate-treated female mice may be due to the known antischistosomular activity of testosterone.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Dehydroepiandrosterone Sulfate / therapeutic use*
  • Female
  • Mice
  • Schistosoma mansoni*
  • Schistosomiasis mansoni / drug therapy*

Substances

  • Dehydroepiandrosterone Sulfate